Search

Your search keyword '"Iannuzzo, G."' showing total 6 results
Start Over Author "Iannuzzo, G." Publisher oxford university press (oup)
6 results on '"Iannuzzo, G."'

1. Efficacy, safety, adherence and persistence of PCSK9 inhibitors in clinical practice: a single country, multicenter, observational study (AT-TARGET-IT)

Author

Gargiulo, P, primary, Basile, C, additional, Calabro', P, additional, Catalano, A, additional, Merlini, P A, additional, Iannuzzo, G, additional, Ciccone, M M, additional, Paloscia, L, additional, Varbella, F, additional, Brunetti, N D, additional, Paolillo, S, additional, Marzano, F, additional, Indolfi, C, additional, and Perrone-Filardi, P, additional

Published
2023
Full Text
View/download PDF

2. PCSK9 inhibitors: effectiveness of treatment and changes in background lipid-lowering therapy in a real world Italian population. The AT-TARGET-IT study

Author

Perrone-Filardi, P, primary, Basile, C, additional, Asile, G, additional, Abbate, C, additional, Catalano, A, additional, Merlini, P A, additional, Calabro', P, additional, Iannuzzo, G, additional, Ciccone, M M, additional, Paloscia, L, additional, Varbella, F, additional, Brunetti, N D, additional, Indolfi, C, additional, Paolillo, S, additional, and Gargiulo, P, additional

Published
2022
Full Text
View/download PDF

6. Association of apolipoprotein levels with peripheral arterial disease: a meta-analysis of literature studies

Author

Martina Chiurazzi, M. Tripaldella, Matteo Nicola Dario Di Minno, Ilenia Calcaterra, Francesco Forte, Roberta Clara Orsini, Roberta Lupoli, Gabriella Iannuzzo, Forte, F., Calcaterra, I., Lupoli, R., Orsini, R. C., Chiurazzi, M., Tripaldella, M., Iannuzzo, G., and Di Minno, M. N. D.

Subjects
medicine.medical_specialty, Inverse Association, Apolipoprotein B, Epidemiology, Arterial disease, 030204 cardiovascular system & hematology, Gastroenterology, Lower limb, Mean difference, Peripheral Arterial Disease, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Internal medicine, Humans, Medicine, 030212 general & internal medicine, Apolipoproteins B, Apolipoprotein A-I, Peripheral artery disease, biology, business.industry, ApoA-I, nutritional and metabolic diseases, Atherosclerosis, ApoB/apoA-I ratio, Confidence interval, Peripheral, body regions, Apolipoproteins, Meta-analysis, biology.protein, lipids (amino acids, peptides, and proteins), ApoB, Cardiology and Cardiovascular Medicine, business
Abstract

Aims Lower limb peripheral artery disease (PAD) is a leading cause of atherosclerotic cardiovascular disease (ASCVD). Discordant data are available on the association between apolipoprotein and PAD. We performed a meta-analyses on the association between apolipoprotein (apo)B, apoA-I, and apoB/apoA-I ratio with PAD. Methods and results PubMed, Web of Science, Scopus databases were systematically searched. Studies providing data about apoB, apoA-I, apoB/apoA-I ratio in PAD subjects and non-PAD controls were included. Differences between PAD and non-PAD subjects were expressed as mean difference (MD) with pertinent 95% confidence intervals (95%CI). Twenty-two studies were included. Peripheral artery disease subjects showed higher apoB (MD: 12.5 mg/dL, 95%CI: 2.14, 22.87) and lower apoA-I levels (MD: −7.11 mg/dL, 95%CI: −11.94, −2.28) than non-PAD controls. Accordingly, ApoB/ApoA-I ratio resulted higher in PAD subjects than non-PAD controls (MD: 0.11, 95% CI: 0.00, 0.21). Non-HDL-C showed a direct association with the difference in apoB (z-value: 4.72, P Conclusions Our meta-analysis suggests that PAD subjects exhibit increased apoB and reduced apoA-I levels, accompanied by an increased apoB/apoA-I ratio as compared with non-PAD controls.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results